Sotorasib covalently binds to the switch pocket of KRAS G12C mutant protein, specifically inhibits GTPase activity and blocks abnormal RAS signaling.
Authentic
Guarantee
Fast Delivery
Privacy Sotorasib (also known as LUMAKRAS) is an innovative targeted therapy for KRASG12C-mutant non-small cell lung cancer (NSCLC). Due to its unique pharmac···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 70
Publicly available information shows that the price of the original brand-name drug Sotorasib is generally between $1,300 and $2,500, with the exact p···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 70
Sotorasib is a targeted therapy for KRAS G12C-mutant non-small cell lung cancer (NSCLC). Its price varies significantly depending on region, dosage, p···【Read More】
Update: 25 Feb,2026Source: Haiou HealthViews: 70
Sotorasib (generic name: Sotorasib) is a prescription drug targeting a specific gene mutation (KRAS G12C) in non-small cell lung cancer. Its price is ···【Read More】
Update: 25 Feb,2026Source: Haiou HealthViews: 70
The price of Sotorasib varies significantly depending on the region, purchase channel, and dosage. The specific price should be confirmed with the hos···【Read More】
Update: 25 Feb,2026Source: Haiou HealthViews: 71
Copyright2024@ BIGBEAR All right reserved BIGBEAR



